This webinar is brought to you by GLiMR COST Action together with Cercare Medical. This is a recording of the live session that is now available on-demand.
Join us with Professor Kim Beuschau Mouridsen, Dr. Mikkel Bo Hansen, and Dr. Ronald Borra, MD, for an introduction to new unique perfusion biomarkers (CTH, OEF, CMRO2) that are derived from routine dynamic imaging protocols and that have been shown to provide important insights into brain tissue metabolism.
Additionally, they briefly talk about how these biomarkers are currently used for training an AI algorithm targeted at improving brain tumor grading and prognosis.
Kim Beuschau Mouridsen, PhD, founder and Managing Director at Cercare Medical
Mikkel Bo Hansen, PhD, founder and CSO at Cercare Medical
Ronald Borra, MD, PhD, CMO at Cercare Medical